文献速递前列腺癌

局灶高强度聚焦超声与主动监测治疗低至中危前列腺癌的成本效用分析:基于马尔可夫多状态模型

Cost-utility analysis of focal high-intensity focussed ultrasound vs active surveillance for low- to intermediate-risk prostate cancer using a Markov multi-state model.
PubMed 文献 · BJU Int · 2019-07-31

在法国,从国家医保支付方视角构建马尔可夫多状态模型,比较局灶高强度聚焦超声(F-HIFU)与主动监测(AS)治疗低至中危前列腺癌的10年成本效用,并做30年时限的次要分析。结果提示AS相比F-HIFU具有成本效用,但不确定性高。

要点

  • 模型设定5个健康状态:初始状态(AS或F-HIFU)、根治性前列腺切除术、放疗、转移和死亡。
  • 1000例虚构队列随访10年,F-HIFU较AS多花费207520欧元、少获得382个QALY。
  • 在0至100000欧元/QALY的阈值范围内,AS具有成本效用的概率为56.5%至60%。

核心结论

  • 基于现有已发表数据,结果提示在低至中危前列腺癌患者中AS相比F-HIFU具有成本效用,但不确定性高。
  • 作者认为这一不确定性需通过持续用新发表数据更新模型来降低,理想情况下通过纳入成本效用分析的随机临床试验来降低。

研究设计与样本

  • 研究构建马尔可夫多状态模型,从法国国家健康保险视角进行分析,时间范围为10年,成本和效果均采用4%贴现率。
  • 次要分析采用30年时间范围,成本以2016年欧元(€)表示,效果以质量调整生命年(QALY)表示。
  • 模型参数(健康状态间转移概率、健康状态的成本和效用)依据系统文献综述(PubMed)和随机效应Meta分析。
  • 模型中F-HIFU的成本为法国卫生部授予HIFU整体治疗前列腺癌的临时定价(6047欧元)。
  • 模型使用Microsoft Excel 2010进行分析,模型参数值的不确定性通过概率分析处理。

主要发现

  • 模型的5个健康状态为:初始状态(AS或F-HIFU)、根治性前列腺切除术、放疗、转移和死亡。
  • 从初始F-HIFU状态出发的转移概率基于4篇符合Meta分析纳入条件的文章,均为非对照研究。
  • 效用值基于美国加利福尼亚州圣迭戈的一个单队列。
  • 对于1000例虚构队列随访10年,F-HIFU较AS多花费207520欧元,且少获得382个QALY。
  • 在0至100000欧元/QALY的阈值范围内,AS相比F-HIFU具有成本效用的概率为56.5%至60%;30年时间范围下不确定性水平相近。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 从初始F-HIFU状态出发的转移概率所依据的4篇文章均为非对照研究。
  • 效用值仅基于美国加利福尼亚州圣迭戈的一个单队列。
  • 结果提示AS相比F-HIFU具有成本效用,但不确定性高。
  • 作者认为这一不确定性需通过持续用新发表数据更新模型来降低,理想情况下通过纳入成本效用分析的随机临床试验来降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To estimate the relative cost-effectiveness of focal high-intensity focussed ultrasound (F-HIFU) compared to active surveillance (AS) in patients with low- to intermediate-risk prostate cancer, in France. PATIENTS AND METHODS: A Markov multi-state model was elaborated for this purpose. Our analyses were conducted from the French National Health Insurance perspective, with a time horizon of 10 years and a 4% discount rate for cost and effectiveness. A secondary analysis used a 30-year time horizon. Costs are presented in 2016 Euros (€), and effectiveness is expressed as quality-adjusted life years (QALYs). Model parameters' value (probabilities for transitions between health states, and cost and utility of health states) is supported by systematic literature reviews (PubMed) and random effect meta-analyses. The cost of F-HIFU in our model was the temporary tariff attributed by the French Ministry of Health to the overall treatment of prostate cancer by HIFU (€6047). Our model was analysed using Microsoft Excel 2010 (Microsoft Corp., Redmond, WA, USA). Uncertainty about the value of the model parameters was handled through probabilistic analyses. RESULTS: The five health states of our model were as follows: initial state (AS or F-HIFU), radical prostatectomy, radiation therapy, metastasis, and death. Transition probabilities from the initial F-HIFU state relied on four articles eligible for our meta-analyses. All were non-comparative studies. Utilities relied on a single cohort in San Diego, CA, USA. For a fictive cohort of 1000 individuals followed for 10 years, F-HIFU would be €207 520 more costly and would yield 382 less QALYs than AS, which means that AS is cost-effective when compared to F-HIFU. For a threshold value varying from €0 to 100 000/QALY, the probability of AS being cost-effective compared to F-HIFU varied from 56.5% to 60%. This level of uncertainty was in the same range with a 30-year time horizon. CONCLUSION: Given existing published data, our results suggest that AS is cost-effective compared to F-HIFU in patients with low- and intermediate-risk prostate cancer, but with high uncertainty. This uncertainty must be scaled down by continuing to supply the model with new published data and ideally through a randomised clinical trial that includes cost-effectiveness analyses.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Bénard A, Duroux T, Robert G, et al. Cost-utility analysis of focal high-intensity focussed ultrasound vs active surveillance for low- to intermediate-risk prostate cancer using a Markov multi-state model. BJU Int. 2019. PMID: 31298775. doi:10.1111/bju.14867

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。